<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Eric J. Miller - Multiple Myeloma Medical Portal</title>
    <link href="https://cdn.jsdelivr.net/npm/tailwindcss@2.2.19/dist/tailwind.min.css" rel="stylesheet">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.4.0/css/all.min.css">
    <script src="https://cdn.jsdelivr.net/npm/chart.js@3.9.1/dist/chart.min.js"></script>
    <style>
        :root {
            --primary: #1E3A8A;
            --secondary: #0D9488;
            --accent: #F97316;
            --bg-light: #F9FAFB;
            --text-dark: #1F2937;
        }
        
        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', 'Roboto', 'Oxygen', 'Ubuntu', 'Cantarell', 'Fira Sans', 'Droid Sans', 'Helvetica Neue', sans-serif;
            background: var(--bg-light);
            color: var(--text-dark);
        }
        
        .dark-mode {
            background: #1F2937;
            color: #F9FAFB;
        }
        
        .dark-mode .card {
            background: #374151;
            border-color: #4B5563;
        }
        
        .card {
            background: white;
            border-radius: 12px;
            box-shadow: 0 4px 6px rgba(0, 0, 0, 0.05);
            transition: all 0.3s ease;
        }
        
        .card:hover {
            box-shadow: 0 10px 15px rgba(0, 0, 0, 0.1);
            transform: translateY(-2px);
        }
        
        .btn-primary {
            background: var(--primary);
            color: white;
            padding: 0.75rem 1.5rem;
            border-radius: 8px;
            font-weight: 600;
            transition: all 0.3s ease;
        }
        
        .btn-primary:hover {
            background: #1E40AF;
            transform: translateY(-1px);
            box-shadow: 0 4px 12px rgba(30, 58, 138, 0.3);
        }
        
        .stat-card {
            border-left: 4px solid var(--secondary);
        }
        
        .high-risk {
            color: #DC2626;
            font-weight: 700;
        }
        
        .chromosome-box {
            display: inline-block;
            width: 60px;
            height: 80px;
            background: linear-gradient(to bottom, #3B82F6, #1E40AF);
            border-radius: 8px;
            margin: 5px;
            position: relative;
        }
        
        .probe-dot {
            width: 12px;
            height: 12px;
            border-radius: 50%;
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            box-shadow: 0 0 10px currentColor;
        }
        
        .timeline-item {
            border-left: 3px solid var(--secondary);
            padding-left: 20px;
            margin-bottom: 20px;
            position: relative;
        }
        
        .timeline-item::before {
            content: '';
            width: 12px;
            height: 12px;
            background: var(--secondary);
            border-radius: 50%;
            position: absolute;
            left: -7.5px;
            top: 0;
        }
        
        .progress-bar {
            height: 30px;
            background: #E5E7EB;
            border-radius: 15px;
            overflow: hidden;
            position: relative;
        }
        
        .progress-fill {
            height: 100%;
            background: linear-gradient(90deg, var(--secondary), var(--primary));
            transition: width 0.5s ease;
        }
        
        .tab-button {
            padding: 12px 24px;
            border-bottom: 3px solid transparent;
            cursor: pointer;
            transition: all 0.3s ease;
        }
        
        .tab-button:hover {
            background: rgba(30, 58, 138, 0.05);
        }
        
        .tab-button.active {
            border-bottom-color: var(--primary);
            color: var(--primary);
            font-weight: 600;
        }
        
        .tab-content {
            display: none;
        }
        
        .tab-content.active {
            display: block;
            animation: fadeIn 0.3s ease;
        }
        
        @keyframes fadeIn {
            from { opacity: 0; transform: translateY(10px); }
            to { opacity: 1; transform: translateY(0); }
        }
        
        .sticky-header {
            position: sticky;
            top: 0;
            z-index: 100;
            background: white;
            box-shadow: 0 2px 10px rgba(0, 0, 0, 0.1);
        }
        
        .dark-mode .sticky-header {
            background: #1F2937;
        }
        
        .accordion-header {
            cursor: pointer;
            padding: 16px;
            background: var(--bg-light);
            border-radius: 8px;
            margin-bottom: 8px;
            font-weight: 600;
            transition: all 0.3s ease;
        }
        
        .accordion-header:hover {
            background: #E5E7EB;
        }
        
        .accordion-content {
            max-height: 0;
            overflow: hidden;
            transition: max-height 0.5s ease;
        }
        
        .accordion-content.open {
            max-height: 3000px;
        }
        
        .table-responsive {
            overflow-x: auto;
        }
        
        table {
            width: 100%;
            border-collapse: collapse;
        }
        
        th, td {
            padding: 12px;
            text-align: left;
            border-bottom: 1px solid #E5E7EB;
        }
        
        th {
            background: var(--bg-light);
            font-weight: 700;
            color: var(--primary);
        }
        
        tr:hover {
            background: rgba(30, 58, 138, 0.02);
        }
        
        @media print {
            .no-print {
                display: none !important;
            }
            
            .card {
                box-shadow: none;
                border: 1px solid #E5E7EB;
                page-break-inside: avoid;
            }
            
            body {
                background: white;
            }
        }
        
        @media (max-width: 768px) {
            .stat-card {
                margin-bottom: 16px;
            }
            
            .tab-button {
                font-size: 14px;
                padding: 10px 16px;
            }
        }
        
        .tooltip {
            position: relative;
            display: inline-block;
        }
        
        .tooltip .tooltiptext {
            visibility: hidden;
            width: 200px;
            background-color: #374151;
            color: white;
            text-align: center;
            border-radius: 6px;
            padding: 8px;
            position: absolute;
            z-index: 1;
            bottom: 125%;
            left: 50%;
            margin-left: -100px;
            opacity: 0;
            transition: opacity 0.3s;
            font-size: 12px;
        }
        
        .tooltip:hover .tooltiptext {
            visibility: visible;
            opacity: 1;
        }
        
        .chart-container {
            position: relative;
            height: 400px;
            margin: 20px 0;
        }
        
        .survival-scenario {
            border: 2px solid #E5E7EB;
            border-radius: 8px;
            padding: 16px;
            margin: 12px 0;
            transition: all 0.3s ease;
        }
        
        .survival-scenario:hover {
            border-color: var(--primary);
            box-shadow: 0 4px 12px rgba(30, 58, 138, 0.1);
        }
    
        
        /* ===== UX IMPROVEMENTS ===== */
        
        /* Focus states for keyboard navigation */
        a:focus, button:focus, input:focus, select:focus {
            outline: 3px solid var(--secondary);
            outline-offset: 2px;
        }
        
        /* Smooth scrolling for entire page */
        html {
            scroll-behavior: smooth;
        }
        
        /* Better link states */
        a {
            transition: color 0.2s ease, opacity 0.2s ease;
        }
        
        a:hover {
            opacity: 0.8;
        }
        
        /* Active navigation indicator */
        .tab-button.active {
            position: relative;
        }
        
        .tab-button.active::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            right: 0;
            height: 3px;
            background: var(--primary);
            border-radius: 3px 3px 0 0;
        }
        
        /* Scroll indicator for sections */
        section {
            scroll-margin-top: 140px;
        }
        
        /* Better button feedback */
        .btn-primary {
            position: relative;
            overflow: hidden;
        }
        
        .btn-primary::after {
            content: '';
            position: absolute;
            top: 50%;
            left: 50%;
            width: 0;
            height: 0;
            background: rgba(255,255,255,0.3);
            border-radius: 50%;
            transform: translate(-50%, -50%);
            transition: width 0.3s ease, height 0.3s ease;
        }
        
        .btn-primary:active::after {
            width: 200px;
            height: 200px;
        }
        
        /* Loading state for canvases */
        canvas {
            background: linear-gradient(135deg, #f1f5f9 0%, #e2e8f0 100%);
        }
        
        /* Better accordion UX */
        .accordion-header {
            position: relative;
            padding-right: 40px;
        }
        
        .accordion-header .fa-chevron-down {
            transition: transform 0.3s ease;
        }
        
        .accordion-content.open + .accordion-header .fa-chevron-down,
        .accordion-header.open .fa-chevron-down {
            transform: rotate(180deg);
        }
        
        /* Progress indicator styling */
        .progress-bar {
            position: relative;
            overflow: hidden;
        }
        
        .progress-fill::after {
            content: '';
            position: absolute;
            top: 0;
            left: 0;
            right: 0;
            bottom: 0;
            background: linear-gradient(90deg, transparent, rgba(255,255,255,0.3), transparent);
            animation: progressShimmer 2s infinite;
        }
        
        @keyframes progressShimmer {
            0% { transform: translateX(-100%); }
            100% { transform: translateX(100%); }
        }
        
        /* Table row hover for better scanning */
        tr {
            transition: background-color 0.2s ease;
        }
        
        tr:hover {
            background: rgba(30, 58, 138, 0.03) !important;
        }
        
        /* Better touch targets for mobile */
        @media (max-width: 768px) {
            .tab-button, .btn-primary, .accordion-header {
                min-height: 44px;
            }
            
            button, a {
                min-height: 44px;
                min-width: 44px;
            }
        }
        
        /* Reduce motion for users who prefer it */
        @media (prefers-reduced-motion: reduce) {
            *, *::before, *::after {
                animation-duration: 0.01ms !important;
                animation-iteration-count: 1 !important;
                transition-duration: 0.01ms !important;
            }
            
            html {
                scroll-behavior: auto;
            }
        }
        
        /* Print improvements */
        @media print {
            .no-print, #particles-canvas, canvas {
                display: none !important;
            }
            
            .card {
                break-inside: avoid;
                box-shadow: none;
                border: 1px solid #e5e7eb;
            }
            
            section {
                break-before: page;
            }
            
            a {
                text-decoration: underline;
            }
            
            a[href^="http"]::after {
                content: " (" attr(href) ")";
                font-size: 0.8em;
                color: #666;
            }
        }
        
        /* Tooltip improvements */
        .tooltip .tooltiptext {
            font-size: 13px;
            line-height: 1.4;
            max-width: 280px;
        }
        
        /* Loading skeleton for charts */
        .chart-container::before {
            content: 'Loading chart...';
            display: flex;
            align-items: center;
            justify-content: center;
            position: absolute;
            top: 0;
            left: 0;
            right: 0;
            bottom: 0;
            background: rgba(255,255,255,0.9);
            color: #9ca3af;
            font-size: 14px;
            opacity: 0;
            transition: opacity 0.3s ease;
            pointer-events: none;
        }
        
        .chart-container:empty::before {
            opacity: 1;
        }


        
        /* ===== UX IMPROVEMENTS ===== */
        
        /* Focus states for keyboard navigation */
        a:focus, button:focus, input:focus, select:focus {
            outline: 3px solid var(--secondary);
            outline-offset: 2px;
        }
        
        /* Smooth scrolling for entire page */
        html {
            scroll-behavior: smooth;
        }
        
        /* Better link states */
        a {
            transition: color 0.2s ease, opacity 0.2s ease;
        }
        
        a:hover {
            opacity: 0.8;
        }
        
        /* Active navigation indicator */
        .tab-button.active {
            position: relative;
        }
        
        .tab-button.active::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            right: 0;
            height: 3px;
            background: var(--primary);
            border-radius: 3px 3px 0 0;
        }
        
        /* Scroll indicator for sections */
        section {
            scroll-margin-top: 140px;
        }
        
        /* Better button feedback */
        .btn-primary {
            position: relative;
            overflow: hidden;
        }
        
        .btn-primary::after {
            content: '';
            position: absolute;
            top: 50%;
            left: 50%;
            width: 0;
            height: 0;
            background: rgba(255,255,255,0.3);
            border-radius: 50%;
            transform: translate(-50%, -50%);
            transition: width 0.3s ease, height 0.3s ease;
        }
        
        .btn-primary:active::after {
            width: 200px;
            height: 200px;
        }
        
        /* Loading state for canvases */
        canvas {
            background: linear-gradient(135deg, #f1f5f9 0%, #e2e8f0 100%);
        }
        
        /* Better accordion UX */
        .accordion-header {
            position: relative;
            padding-right: 40px;
        }
        
        .accordion-header .fa-chevron-down {
            transition: transform 0.3s ease;
        }
        
        .accordion-content.open + .accordion-header .fa-chevron-down,
        .accordion-header.open .fa-chevron-down {
            transform: rotate(180deg);
        }
        
        /* Progress indicator styling */
        .progress-bar {
            position: relative;
            overflow: hidden;
        }
        
        .progress-fill::after {
            content: '';
            position: absolute;
            top: 0;
            left: 0;
            right: 0;
            bottom: 0;
            background: linear-gradient(90deg, transparent, rgba(255,255,255,0.3), transparent);
            animation: progressShimmer 2s infinite;
        }
        
        @keyframes progressShimmer {
            0% { transform: translateX(-100%); }
            100% { transform: translateX(100%); }
        }
        
        /* Table row hover for better scanning */
        tr {
            transition: background-color 0.2s ease;
        }
        
        tr:hover {
            background: rgba(30, 58, 138, 0.03) !important;
        }
        
        /* Better touch targets for mobile */
        @media (max-width: 768px) {
            .tab-button, .btn-primary, .accordion-header {
                min-height: 44px;
            }
            
            button, a {
                min-height: 44px;
                min-width: 44px;
            }
        }
        
        /* Reduce motion for users who prefer it */
        @media (prefers-reduced-motion: reduce) {
            *, *::before, *::after {
                animation-duration: 0.01ms !important;
                animation-iteration-count: 1 !important;
                transition-duration: 0.01ms !important;
            }
            
            html {
                scroll-behavior: auto;
            }
        }
        
        /* Print improvements */
        @media print {
            .no-print, #particles-canvas, canvas {
                display: none !important;
            }
            
            .card {
                break-inside: avoid;
                box-shadow: none;
                border: 1px solid #e5e7eb;
            }
            
            section {
                break-before: page;
            }
            
            a {
                text-decoration: underline;
            }
            
            a[href^="http"]::after {
                content: " (" attr(href) ")";
                font-size: 0.8em;
                color: #666;
            }
        }
        
        /* Tooltip improvements */
        .tooltip .tooltiptext {
            font-size: 13px;
            line-height: 1.4;
            max-width: 280px;
        }
        
        /* Loading skeleton for charts */
        .chart-container::before {
            content: 'Loading chart...';
            display: flex;
            align-items: center;
            justify-content: center;
            position: absolute;
            top: 0;
            left: 0;
            right: 0;
            bottom: 0;
            background: rgba(255,255,255,0.9);
            color: #9ca3af;
            font-size: 14px;
            opacity: 0;
            transition: opacity 0.3s ease;
            pointer-events: none;
        }
        
        .chart-container:empty::before {
            opacity: 1;
        }


        /* Animation Enhancements */
        .chromosome-animated {
            animation: chromosomeFloat 3s ease-in-out infinite;
        }
        
        .probe-animated {
            animation: probePulse 1.5s ease-in-out infinite;
        }
        
        @keyframes chromosomeFloat {
            0%, 100% { transform: translateY(0) rotate(0deg); }
            50% { transform: translateY(-15px) rotate(3deg); }
        }
        
        @keyframes probePulse {
            0%, 100% { 
                transform: translate(-50%, -50%) scale(1); 
                box-shadow: 0 0 10px currentColor; 
            }
            50% { 
                transform: translate(-50%, -50%) scale(1.3); 
                box-shadow: 0 0 25px currentColor, 0 0 40px currentColor; 
            }
        }
        
        .card {
            transition: all 0.4s cubic-bezier(0.4, 0, 0.2, 1);
        }
        
        .card:hover {
            transform: translateY(-5px);
            box-shadow: 0 20px 40px rgba(0, 0, 0, 0.15);
        }
        
        /* Gradient text for headings */
        .gradient-text {
            background: linear-gradient(135deg, var(--primary), var(--secondary));
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
        }
        
        /* Pulsing high-risk badge */
        .high-risk {
            animation: highRiskPulse 2s ease-in-out infinite;
        }
        
        @keyframes highRiskPulse {
            0%, 100% { opacity: 1; }
            50% { opacity: 0.6; }
        }
        
        /* Smooth tab transitions */
        .tab-content {
            transition: opacity 0.3s ease, transform 0.3s ease;
        }
        
        .tab-content:not(.active) {
            opacity: 0;
            transform: translateY(10px);
        }

    </style>
</head>
<body>
<!-- Particle Background -->

<!-- Skip to main content link for accessibility -->
<a href="#dashboard" class="skip-link" style="position:absolute;left:-999px;top:auto;width:1px;height:1px;overflow:hidden;">Skip to main content</a>
<style>
    .skip-link:focus {
        position: fixed !important;
        top: 10px;
        left: 10px;
        width: auto !important;
        height: auto !important;
        padding: 15px 25px;
        background: var(--primary);
        color: white;
        z-index: 9999;
        border-radius: 8px;
        font-weight: 600;
        text-decoration: none;
        box-shadow: 0 4px 12px rgba(0,0,0,0.3);
    }
</style>


<!-- Skip to main content link for accessibility -->
<a href="#dashboard" class="skip-link" style="position:absolute;left:-999px;top:auto;width:1px;height:1px;overflow:hidden;">Skip to main content</a>
<style>
    .skip-link:focus {
        position: fixed !important;
        top: 10px;
        left: 10px;
        width: auto !important;
        height: auto !important;
        padding: 15px 25px;
        background: var(--primary);
        color: white;
        z-index: 9999;
        border-radius: 8px;
        font-weight: 600;
        text-decoration: none;
        box-shadow: 0 4px 12px rgba(0,0,0,0.3);
    }
</style>

<canvas id="particles-canvas" style="position:fixed;top:0;left:0;width:100%;height:100%;z-index:-1;pointer-events:none;"></canvas>


<!-- Sticky Header -->
<header class="sticky-header">
    <div class="container mx-auto px-4 py-4">
        <div class="flex items-center justify-between flex-wrap">
            <div class="flex items-center space-x-3">
                <i class="fas fa-hospital-user text-3xl" style="color: var(--primary);"></i>
                <div>
                    <h1 class="text-2xl font-bold" style="color: var(--primary);">Eric J. Miller Myeloma Portal</h1>
                    <p class="text-sm text-gray-600">DOB: 07/22/1967 | MR#: 3329796 | Dx: 11/07/2025</p>
                </div>
            </div>
            <div class="flex items-center space-x-4 no-print">
                <button onclick="toggleDarkMode()" class="p-2 rounded hover:bg-gray-100" aria-label="Toggle dark mode" title="Toggle dark mode">
                    <i class="fas fa-moon"></i>
                </button>
                <button onclick="window.print()" class="p-2 rounded hover:bg-gray-100" aria-label="Print page" title="Print this page">
                    <i class="fas fa-print"></i>
                </button>
                <button onclick="adjustFontSize('increase')" class="p-2 rounded hover:bg-gray-100" aria-label="Increase font size" title="Increase font size">
                    <i class="fas fa-plus"></i>
                </button>
                <button onclick="adjustFontSize('decrease')" class="p-2 rounded hover:bg-gray-100" aria-label="Decrease font size" title="Decrease font size">
                    <i class="fas fa-minus"></i>
                </button>
            </div>
        </div>
        
        <!-- Navigation -->
        <nav class="mt-4 flex space-x-2 overflow-x-auto no-print">
            <button onclick="scrollToSection('dashboard')" class="tab-button">
                <i class="fas fa-home mr-2"></i>Dashboard
            </button>
            <button onclick="scrollToSection('diagnostics')" class="tab-button">
                <i class="fas fa-microscope mr-2"></i>Diagnostics
            </button>
            <button onclick="scrollToSection('treatment')" class="tab-button">
                <i class="fas fa-pills mr-2"></i>Treatment
            </button>
            <button onclick="scrollToSection('prognosis')" class="tab-button">
                <i class="fas fa-chart-line mr-2"></i>Prognosis
            </button>
            <button onclick="scrollToSection('resources')" class="tab-button">
                <i class="fas fa-book-medical mr-2"></i>Resources
            </button>
        </nav>
    </div>
</header>

<!-- Main Content -->
<main role="main" class="container mx-auto px-4 py-8">

    <!-- Dashboard Section -->
    <section id="dashboard" class="mb-12">
        <!-- Hero Section -->
        <div class="luxury-card reveal p-8 mb-8 text-center">
            <h2 class="text-4xl font-bold mb-2">Eric J. Miller</h2>
            <p class="text-2xl mb-4" style="color: var(--secondary);">High-Risk Smoldering Multiple Myeloma</p>
            <div class="flex justify-center items-center space-x-6 text-sm flex-wrap">
                <span><strong>Diagnosed:</strong> November 7, 2025</span>
                <span><strong>Age:</strong> 57</span>
                <span><strong>Status:</strong> <span class="inline-block px-3 py-1 bg-green-100 text-green-800 rounded-full">Active Treatment</span></span>
            </div>
            <div class="mt-6 flex justify-center space-x-4 flex-wrap">
                <button onclick="scrollToSection('diagnostics')" class="btn-primary">
                    <i class="fas fa-chart-bar mr-2"></i>View Full Report
                </button>
                <button onclick="alert('Next Appointment: Week 4 Labs - January 18, 2026')" class="btn-primary" style="background: var(--secondary);">
                    <i class="fas fa-calendar-alt mr-2"></i>Next Appointment
                </button>
            </div>
        </div>

        <!-- Quick Stats -->
        <div class="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-4 gap-6 mb-8">
            <div class="luxury-card reveal p-6 stat-card">
                <div class="flex items-center justify-between mb-2">
                    <i class="fas fa-dna text-3xl" style="color: var(--secondary);"></i>
                    <span class="high-risk text-sm">HIGH-RISK</span>
                </div>
                <h3 class="text-lg font-bold mb-1">Cytogenetics</h3>
                <p class="text-sm text-gray-600">1q21 gain (4 copies)</p>
                <p class="text-sm text-gray-600">TP53 abnormal (3 copies)</p>
            </div>
            
            <div class="luxury-card reveal p-6 stat-card">
                <div class="flex items-center justify-between mb-2">
                    <i class="fas fa-syringe text-3xl" style="color: var(--secondary);"></i>
                    <span class="text-sm text-green-600 font-semibold">ACTIVE</span>
                </div>
                <h3 class="text-lg font-bold mb-1">Treatment</h3>
                <p class="text-sm text-gray-600">Darzalex (Daratumumab)</p>
                <p class="text-sm text-gray-600">Started: 12/21/2025</p>
            </div>
            
            <div class="luxury-card reveal p-6 stat-card">
                <div class="flex items-center justify-between mb-2">
                    <i class="fas fa-check-circle text-3xl text-green-600"></i>
                    <span class="text-sm text-green-600 font-semibold">EXCELLENT</span>
                </div>
                <h3 class="text-lg font-bold mb-1">Week 3 Labs ‚≠ê</h3>
                <p class="text-sm text-gray-600">WBC: 9.0 ‚úì</p>
                <p class="text-sm text-gray-600">Hgb: 17.0 ‚úì</p>
            </div>
            
            <div class="luxury-card reveal p-6 stat-card">
                <div class="flex items-center justify-between mb-2">
                    <i class="fas fa-clock text-3xl" style="color: var(--accent);"></i>
                    <span class="text-sm" style="color: var(--accent);">UPCOMING</span>
                </div>
                <h3 class="text-lg font-bold mb-1">Timeline</h3>
                <p class="text-sm text-gray-600">Week 4 Labs: Jan 18</p>
                <p class="text-sm text-gray-600">Week 12: April 2026</p>
            </div>
        </div>

        
        <!-- Interactive DNA Visualization -->
        <div class="luxury-card reveal p-6 mb-8">
            <h3 class="text-xl font-bold mb-4" style="color: var(--primary);"><i class="fas fa-dna mr-2"></i>üß¨ Your Genetic Profile - Interactive Visualization</h3>
            <p class="text-gray-600 mb-4">This animated DNA helix highlights your genetic abnormalities. The highlighted regions show where your 1q21 gain and TP53 abnormality are located.</p>
            <div id="dna-container" style="background: linear-gradient(135deg, #1e3a5f 0%, #0f172a 100%); border-radius: 12px; padding: 20px;">
                <canvas id="dna-helix" style="width: 100%; height: 200px;"></canvas>
            </div>
        </div>

<!-- Navigation Tiles -->
        <div class="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-3 gap-6 mb-8">
            <div class="luxury-card reveal p-6 cursor-pointer" onclick="scrollToSection('diagnostics')">
                <div class="flex items-center mb-4">
                    <i class="fas fa-microscope text-4xl mr-4" style="color: var(--primary);"></i>
                    <h3 class="text-xl font-bold">Diagnostic Results</h3>
                </div>
                <ul class="space-y-2 text-sm mb-4">
                    <li><i class="fas fa-chevron-right mr-2"></i>Bone Marrow Biopsy</li>
                    <li><i class="fas fa-chevron-right mr-2"></i>FISH Panel</li>
                    <li><i class="fas fa-chevron-right mr-2"></i>Baseline Labs</li>
                    <li><i class="fas fa-chevron-right mr-2"></i>Day-5 Response</li>
                </ul>
                <button class="text-sm font-semibold" style="color: var(--primary);">VIEW DETAILS ‚Üí</button>
            </div>
            
            <div class="luxury-card reveal p-6 cursor-pointer" onclick="scrollToSection('treatment')">
                <div class="flex items-center mb-4">
                    <i class="fas fa-pills text-4xl mr-4" style="color: var(--primary);"></i>
                    <h3 class="text-xl font-bold">Treatment Plan</h3>
                </div>
                <ul class="space-y-2 text-sm mb-4">
                    <li><i class="fas fa-chevron-right mr-2"></i>Daratumumab Monotherapy</li>
                    <li><i class="fas fa-chevron-right mr-2"></i>MRD Monitoring</li>
                    <li><i class="fas fa-chevron-right mr-2"></i>CAR-T Planning</li>
                    <li><i class="fas fa-chevron-right mr-2"></i>Maintenance</li>
                </ul>
                <button class="text-sm font-semibold" style="color: var(--primary);">VIEW DETAILS ‚Üí</button>
            </div>
            
            <div class="luxury-card reveal p-6 cursor-pointer" onclick="scrollToSection('prognosis')">
                <div class="flex items-center mb-4">
                    <i class="fas fa-chart-line text-4xl mr-4" style="color: var(--primary);"></i>
                    <h3 class="text-xl font-bold">Prognosis Calculator</h3>
                </div>
                <ul class="space-y-2 text-sm mb-4">
                    <li><i class="fas fa-chevron-right mr-2"></i>Life Expectancy</li>
                    <li><i class="fas fa-chevron-right mr-2"></i>Quality of Life</li>
                    <li><i class="fas fa-chevron-right mr-2"></i>Scenario Modeling</li>
                    <li><i class="fas fa-chevron-right mr-2"></i>Timeline Visualizer</li>
                </ul>
                <button class="text-sm font-semibold" style="color: var(--primary);">VIEW DETAILS ‚Üí</button>
            </div>
        </div>

        <!-- Timeline -->
        <div class="luxury-card reveal p-8">
            <h3 class="text-2xl font-bold mb-6">Medical Timeline</h3>
            <div class="space-y-4">
                <div class="timeline-item">
                    <p class="font-semibold">January 2, 2026</p>
                    <p class="text-gray-600">Week 2 CBC Results: All values normal, continued excellent response ‚úì</p>
                </div>
                <div class="timeline-item">
                    <p class="font-semibold">December 26, 2025</p>
                    <p class="text-gray-600">Day 5 CBC Results: Excellent Response ‚úì</p>
                </div>
                <div class="timeline-item">
                    <p class="font-semibold">December 21, 2025</p>
                    <p class="text-gray-600">First Daratumumab Infusion Completed</p>
                </div>
                <div class="timeline-item">
                    <p class="font-semibold">November 26, 2025</p>
                    <p class="text-gray-600">FISH Results: High-Risk Cytogenetics (1q21 gain, TP53 abnormal)</p>
                </div>
                <div class="timeline-item">
                    <p class="font-semibold">November 7, 2025</p>
                    <p class="text-gray-600">Bone Marrow Biopsy: 8-10% Kappa-Restricted Plasma Cells</p>
                </div>
                <div class="timeline-item">
                    <p class="font-semibold">November 7, 2025</p>
                    <p class="text-gray-600">Diagnosis: High-Risk Smoldering Multiple Myeloma</p>
                </div>
            </div>
        </div>
    </section>

    <!-- Diagnostics Section -->
    <section id="diagnostics" class="mb-12">
        <h2 class="display-medium reveal">Diagnostic Results</h2>
        
        <!-- Tabs -->
        <div class="luxury-card reveal mb-6">
            <div class="flex border-b overflow-x-auto no-print">
                <button class="tab-button active" onclick="switchTab('bone-marrow')">Bone Marrow</button>
                <button class="tab-button" onclick="switchTab('fish')">FISH Panel</button>
                <button class="tab-button" onclick="switchTab('baseline-labs')">Baseline Labs</button>
                <button class="tab-button" onclick="switchTab('day5')">Day-5 Response</button>
                <button class="tab-button" onclick="switchTab('week2')">Week 2 Labs</button>
                <button class="tab-button active" onclick="switchTab('week3')">Week 3 Labs ‚≠ê</button>
            </div>
            
            <!-- Bone Marrow Tab -->
            <div id="bone-marrow" class="tab-content active p-6">
                <h3 class="text-2xl font-bold mb-4">Bone Marrow Pathology Report</h3>
                <p class="text-sm text-gray-600 mb-4">Date: 11/07/2025 | Pathologist: Dr. Amy Lynn Jencks, DO</p>
                
                <div class="bg-blue-50 border-l-4 border-blue-500 p-4 mb-6">
                    <h4 class="font-bold text-lg mb-2">DIAGNOSIS: Plasma Cell Neoplasm</h4>
                    <ul class="space-y-2">
                        <li><i class="fas fa-check text-blue-600 mr-2"></i>8-10% kappa-restricted plasma cells</li>
                        <li><i class="fas fa-check text-blue-600 mr-2"></i>CD56+ (aberrant marker)</li>
                        <li><i class="fas fa-check text-blue-600 mr-2"></i>Focal cyclin D1+ (10% of plasma cells)</li>
                    </ul>
                </div>
                
                <div class="mb-6">
                    <h4 class="font-bold text-lg mb-3">Flow Cytometry Summary</h4>
                    <div class="table-responsive">
                        <table>
                            <thead>
                                <tr>
                                    <th>Marker</th>
                                    <th>Expression</th>
                                    <th>Percentage</th>
                                    <th>Significance</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>CD138</td>
                                    <td><span class="text-green-600 font-semibold">Positive</span></td>
                                    <td>8-10%</td>
                                    <td>Plasma cell marker</td>
                                </tr>
                                <tr>
                                    <td>CD38</td>
                                    <td><span class="text-green-600 font-semibold">Bright Positive</span></td>
                                    <td>9%</td>
                                    <td>Target for Daratumumab</td>
                                </tr>
                                <tr>
                                    <td>CD56</td>
                                    <td><span class="text-red-600 font-semibold">Positive (Aberrant)</span></td>
                                    <td>9%</td>
                                    <td>High-risk marker</td>
                                </tr>
                                <tr>
                                    <td>Kappa</td>
                                    <td><span class="text-green-600 font-semibold">Restricted</span></td>
                                    <td>7%</td>
                                    <td>Monoclonal</td>
                                </tr>
                                <tr>
                                    <td>Lambda</td>
                                    <td><span class="text-gray-600">Negative</span></td>
                                    <td>1%</td>
                                    <td>Confirms clonality</td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                </div>
                
                <div class="bg-yellow-50 border-l-4 border-yellow-500 p-4">
                    <h4 class="font-bold mb-2">Clinical Interpretation</h4>
                    <p>Consistent with plasma cell myeloma/smoldering myeloma. The presence of CD56 and focal cyclin D1 expression suggests a high-risk disease profile requiring aggressive treatment approach.</p>
                </div>
            </div>
            
            <!-- FISH Panel Tab -->
            <div id="fish" class="tab-content p-6">
                <h3 class="text-2xl font-bold mb-4">üß¨ Fluorescence In-Situ Hybridization (FISH)</h3>
                <p class="text-sm text-gray-600 mb-4">Collected: 11/07/2025 | Reported: 11/26/2025 | Lab: LabCorp Oncology</p>
                
                <div class="bg-red-50 border-l-4 border-red-500 p-4 mb-6">
                    <h4 class="font-bold text-lg mb-2 text-red-700">‚ö†Ô∏è HIGH-RISK CYTOGENETICS DETECTED</h4>
                    <p>Multiple high-risk abnormalities requiring intensified therapy (Daratumumab recommended)</p>
                </div>
                
                <!-- Chromosome Visual -->
                <div class="mb-8">
                    <h4 class="font-bold text-lg mb-4">Chromosome 1 (1q21 Region) - YOUR RESULT</h4>
                    <div class="flex items-center justify-center mb-4 flex-wrap">
                        <div class="text-center mx-4">
                            <p class="text-sm mb-2 font-semibold">Normal (2 copies)</p>
                            <div class="flex">
                                <div class="chromosome-box">
                                    <div class="probe-dot" style="background: #EF4444;"></div>
                                </div>
                                <div class="chromosome-box">
                                    <div class="probe-dot" style="background: #EF4444;"></div>
                                </div>
                            </div>
                        </div>
                        <div class="text-4xl mx-4">‚Üí</div>
                        <div class="text-center mx-4">
                            <p class="text-sm mb-2 font-semibold high-risk">YOUR RESULT (4 copies)</p>
                            <div class="flex">
                                <div class="chromosome-box">
                                    <div class="probe-dot" style="background: #EF4444;"></div>
                                </div>
                                <div class="chromosome-box">
                                    <div class="probe-dot" style="background: #EF4444;"></div>
                                </div>
                                <div class="chromosome-box">
                                    <div class="probe-dot" style="background: #EF4444;"></div>
                                </div>
                                <div class="chromosome-box">
                                    <div class="probe-dot" style="background: #EF4444;"></div>
                                </div>
                            </div>
                        </div>
                    </div>
                    <div class="bg-blue-50 p-4 rounded-lg">
                        <p class="font-semibold mb-2">Clinical Significance:</p>
                        <ul class="text-sm space-y-1">
                            <li>‚Ä¢ CKS1B & MCL1 genes on 1q21 are amplified</li>
                            <li>‚Ä¢ Associated with shorter progression-free survival</li>
                            <li>‚Ä¢ Requires intensified therapy (Daratumumab recommended)</li>
                        </ul>
                    </div>
                </div>
                
                <!-- Complete FISH Results Table -->
                <div class="mb-6">
                    <h4 class="font-bold text-lg mb-3">Complete FISH Results</h4>
                    <div class="table-responsive">
                        <table>
                            <thead>
                                <tr>
                                    <th>Probe</th>
                                    <th>Target</th>
                                    <th>Result</th>
                                    <th>% Cells</th>
                                    <th>Risk Level</th>
                                    <th>Clinical Impact</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr class="bg-red-50">
                                    <td>üî¥ 1q21</td>
                                    <td>CKS1B</td>
                                    <td><strong>4 copies</strong></td>
                                    <td>19.0%</td>
                                    <td><span class="text-red-600 font-bold">HIGH</span></td>
                                    <td>Requires Daratumumab</td>
                                </tr>
                                <tr class="bg-red-50">
                                    <td>üü¢ TP53/17p13</td>
                                    <td>TP53 gene</td>
                                    <td><strong>3 copies</strong></td>
                                    <td>24.0%</td>
                                    <td><span class="text-red-600 font-bold">ULTRA-HIGH</span></td>
                                    <td>Proteasome inhibitor essential</td>
                                </tr>
                                <tr>
                                    <td>üîµ CEP7</td>
                                    <td>Chromosome 7</td>
                                    <td>Trisomy</td>
                                    <td>21.0%</td>
                                    <td><span class="text-yellow-600">Intermediate</span></td>
                                    <td>Genomic instability</td>
                                </tr>
                                <tr>
                                    <td>üü† CEP9</td>
                                    <td>Chromosome 9</td>
                                    <td>Trisomy</td>
                                    <td>19.0%</td>
                                    <td><span class="text-yellow-600">Intermediate</span></td>
                                    <td>Genomic instability</td>
                                </tr>
                                <tr>
                                    <td>üü£ CEP15</td>
                                    <td>Chromosome 15</td>
                                    <td>Trisomy</td>
                                    <td>21.0%</td>
                                    <td><span class="text-yellow-600">Intermediate</span></td>
                                    <td>Genomic instability</td>
                                </tr>
                                <tr class="bg-green-50">
                                    <td>‚ö™ 13q14</td>
                                    <td>DLEU1</td>
                                    <td>Normal</td>
                                    <td>‚Äî</td>
                                    <td><span class="text-green-600">Favorable</span></td>
                                    <td>Good prognostic sign</td>
                                </tr>
                                <tr class="bg-green-50">
                                    <td>‚¨ú t(4;14)</td>
                                    <td>FGFR3/IGH</td>
                                    <td>Not detected</td>
                                    <td>‚Äî</td>
                                    <td><span class="text-green-600">Favorable</span></td>
                                    <td>Avoided high-risk translocation</td>
                                </tr>
                                <tr class="bg-green-50">
                                    <td>‚¨ú t(11;14)</td>
                                    <td>CCND1/IGH</td>
                                    <td>Not detected</td>
                                    <td>‚Äî</td>
                                    <td><span class="text-green-600">Neutral</span></td>
                                    <td>Standard prognosis</td>
                                </tr>
                                <tr class="bg-green-50">
                                    <td>‚¨ú t(14;16)</td>
                                    <td>MAF/IGH</td>
                                    <td>Not detected</td>
                                    <td>‚Äî</td>
                                    <td><span class="text-green-600">Favorable</span></td>
                                    <td>Avoided ultra-high-risk</td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                </div>
                
                <div class="bg-yellow-50 border-l-4 border-yellow-500 p-4">
                    <h4 class="font-bold mb-2">Key Points:</h4>
                    <ul class="space-y-2">
                        <li><strong>Good news:</strong> No t(4;14), t(14;16), or del(13q14)</li>
                        <li><strong>Concerning:</strong> 1q21 gain + TP53 abnormality = ultra-high-risk</li>
                        <li><strong>Action:</strong> Daratumumab monotherapy therapy strongly recommended</li>
                    </ul>
                </div>
            </div>
            
            <!-- Baseline Labs Tab -->
            <div id="baseline-labs" class="tab-content p-6">
                <h3 class="text-2xl font-bold mb-4">Baseline Laboratory Values</h3>
                <p class="text-sm text-gray-600 mb-4">Date: 11/07/2025</p>
                
                <!-- Free Light Chains Visual -->
                <div class="mb-8">
                    <h4 class="font-bold text-lg mb-4">Serum Free Light Chains</h4>
                    <div class="space-y-4">
                        <div>
                            <div class="flex justify-between mb-2">
                                <span class="font-semibold">Free Kappa: 655.69 mg/L</span>
                                <span class="text-red-600 font-bold">33√ó ULN</span>
                            </div>
                            <div class="progress-bar">
                                <div class="progress-fill" style="width: 100%; background: #EF4444;"></div>
                            </div>
                            <p class="text-xs text-gray-600 mt-1">Reference: 0.33-1.94 mg/L</p>
                        </div>
                        <div>
                            <div class="flex justify-between mb-2">
                                <span class="font-semibold">Free Lambda: 12.51 mg/L</span>
                                <span class="text-green-600 font-bold">Normal</span>
                            </div>
                            <div class="progress-bar">
                                <div class="progress-fill" style="width: 40%; background: var(--secondary);"></div>
                            </div>
                            <p class="text-xs text-gray-600 mt-1">Reference: 0.57-2.63 mg/L</p>
                        </div>
                        <div>
                            <div class="flex justify-between mb-2">
                                <span class="font-semibold">Kappa/Lambda Ratio: 52.41</span>
                                <span class="text-red-600 font-bold">>10√ó Abnormal</span>
                            </div>
                            <div class="progress-bar">
                                <div class="progress-fill" style="width: 100%; background: #EF4444;"></div>
                            </div>
                            <p class="text-xs text-gray-600 mt-1">Reference: 0.26-1.65</p>
                        </div>
                    </div>
                </div>
                
                <!-- Complete Labs Table -->
                <div class="mb-6">
                    <h4 class="font-bold text-lg mb-3">Complete Baseline Results</h4>
                    <div class="table-responsive">
                        <table>
                            <thead>
                                <tr>
                                    <th>Test</th>
                                    <th>Value</th>
                                    <th>Reference</th>
                                    <th>Status</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>Free Kappa</td>
                                    <td><strong>655.69 mg/L</strong></td>
                                    <td>0.33-1.94</td>
                                    <td><span class="text-red-600">üî¥ Critical</span></td>
                                </tr>
                                <tr>
                                    <td>Free Lambda</td>
                                    <td>12.51 mg/L</td>
                                    <td>0.57-2.63</td>
                                    <td><span class="text-green-600">üü¢ Normal</span></td>
                                </tr>
                                <tr>
                                    <td>Œ∫/Œª Ratio</td>
                                    <td><strong>52.41</strong></td>
                                    <td>0.26-1.65</td>
                                    <td><span class="text-red-600">üî¥ Critical</span></td>
                                </tr>
                                <tr>
                                    <td>M-Spike (SPEP)</td>
                                    <td><strong>1.07 g/dL</strong></td>
                                    <td>0.00</td>
                                    <td><span class="text-red-600">üî¥ Abnormal</span></td>
                                </tr>
                                <tr>
                                    <td>Hemoglobin</td>
                                    <td>14.2 g/dL</td>
                                    <td>13.5-17.0</td>
                                    <td><span class="text-green-600">üü¢ Normal</span></td>
                                </tr>
                                <tr>
                                    <td>Platelets</td>
                                    <td>245 K/ŒºL</td>
                                    <td>150-400</td>
                                    <td><span class="text-green-600">üü¢ Normal</span></td>
                                </tr>
                                <tr>
                                    <td>WBC</td>
                                    <td>7.8 K/ŒºL</td>
                                    <td>4.0-11.0</td>
                                    <td><span class="text-green-600">üü¢ Normal</span></td>
                                </tr>
                                <tr>
                                    <td>Calcium</td>
                                    <td>9.8 mg/dL</td>
                                    <td>8.5-10.5</td>
                                    <td><span class="text-green-600">üü¢ Normal</span></td>
                                </tr>
                                <tr>
                                    <td>Creatinine</td>
                                    <td>1.1 mg/dL</td>
                                    <td>0.7-1.3</td>
                                    <td><span class="text-green-600">üü¢ Normal</span></td>
                                </tr>
                                <tr>
                                    <td>24hr Urine Protein</td>
                                    <td><strong>1996 mg/g creatinine</strong></td>
                                    <td><150</td>
                                    <td><span class="text-red-600">üî¥ Elevated</span></td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                </div>
                
                <div class="bg-blue-50 p-4 rounded-lg">
                    <h4 class="font-bold mb-2">Summary:</h4>
                    <p>Marked elevation in free kappa light chains (33√ó normal) with significantly abnormal kappa/lambda ratio confirming active myeloma. Kidney function and blood counts remain preserved, indicating early-stage disease caught before end-organ damage.</p>
                </div>
            </div>
            
            <!-- Day-5 Response Tab -->
            <div id="day5" class="tab-content p-6">
                <h3 class="text-2xl font-bold mb-4">Day-5 Post-Daratumumab Response</h3>
                <p class="text-sm text-gray-600 mb-4">Collection: 12/26/2025 12:11 PM</p>
                
                <div class="bg-green-50 border-l-4 border-green-500 p-6 mb-6">
                    <div class="flex items-center mb-4">
                        <i class="fas fa-check-circle text-4xl text-green-600 mr-4"></i>
                        <div>
                            <h4 class="font-bold text-2xl text-green-700">‚úÖ EXCELLENT RESPONSE</h4>
                            <p class="text-green-700">All blood counts within normal range with no myelosuppression</p>
                        </div>
                    </div>
                </div>
                
                <div class="mb-6">
                    <h4 class="font-bold text-lg mb-3">CBC With Differential</h4>
                    <div class="table-responsive">
                        <table>
                            <thead>
                                <tr>
                                    <th>Parameter</th>
                                    <th>Value</th>
                                    <th>Reference</th>
                                    <th>Status</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr class="bg-green-50">
                                    <td>WBC</td>
                                    <td><strong>9.4 K/ŒºL</strong></td>
                                    <td>4.0-11.0</td>
                                    <td><span class="text-green-600 font-bold">‚úÖ Normal</span></td>
                                </tr>
                                <tr class="bg-green-50">
                                    <td>Hemoglobin</td>
                                    <td><strong>16.4 g/dL</strong></td>
                                    <td>13.5-17.0</td>
                                    <td><span class="text-green-600 font-bold">‚úÖ Normal</span></td>
                                </tr>
                                <tr class="bg-green-50">
                                    <td>Platelets</td>
                                    <td><strong>293 K/ŒºL</strong></td>
                                    <td>130-450</td>
                                    <td><span class="text-green-600 font-bold">‚úÖ Normal</span></td>
                                </tr>
                                <tr class="bg-green-50">
                                    <td>ANC (Neutrophils)</td>
                                    <td><strong>5.3 K/ŒºL</strong></td>
                                    <td>1.5-7.8</td>
                                    <td><span class="text-green-600 font-bold">‚úÖ Normal</span></td>
                                </tr>
                                <tr class="bg-green-50">
                                    <td>ALC (Lymphocytes)</td>
                                    <td><strong>3.1 K/ŒºL</strong></td>
                                    <td>0.9-3.9</td>
                                    <td><span class="text-green-600 font-bold">‚úÖ Normal</span></td>
                                </tr>
                                <tr>
                                    <td>Hematocrit</td>
                                    <td>46.4%</td>
                                    <td>40.0-53.0</td>
                                    <td><span class="text-green-600">‚úÖ Normal</span></td>
                                </tr>
                                <tr>
                                    <td>Neutrophils %</td>
                                    <td>56.0%</td>
                                    <td>40-70</td>
                                    <td><span class="text-green-600">‚úÖ Normal</span></td>
                                </tr>
                                <tr>
                                    <td>Lymphocytes %</td>
                                    <td>32.6%</td>
                                    <td>20-40</td>
                                    <td><span class="text-green-600">‚úÖ Normal</span></td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                </div>
                
                <div class="grid grid-cols-1 md:grid-cols-2 gap-6 mb-6">
                    <div class="luxury-card reveal p-6" style="background: linear-gradient(135deg, #10B981 0%, #059669 100%); color: white;">
                        <h4 class="font-bold text-xl mb-4">Clinical Interpretation</h4>
                        <ul class="space-y-3">
                            <li class="flex items-start">
                                <i class="fas fa-check-circle mr-2 mt-1"></i>
                                <span>No acute myelosuppression</span>
                            </li>
                            <li class="flex items-start">
                                <i class="fas fa-check-circle mr-2 mt-1"></i>
                                <span>Robust bone marrow reserve</span>
                            </li>
                            <li class="flex items-start">
                                <i class="fas fa-check-circle mr-2 mt-1"></i>
                                <span>Strong immune system (ALC 3.1 vs expected drop to ~0.3)</span>
                            </li>
                            <li class="flex items-start">
                                <i class="fas fa-check-circle mr-2 mt-1"></i>
                                <span>Suggests Daratumumab-sensitive disease</span>
                            </li>
                        </ul>
                    </div>
                    
                    <div class="luxury-card reveal p-6" style="background: linear-gradient(135deg, #3B82F6 0%, #1E40AF 100%); color: white;">
                        <h4 class="font-bold text-xl mb-4">Next Steps</h4>
                        <div class="space-y-4">
                            <div>
                                <p class="font-semibold mb-1">Week 4 Labs (Due: January 18, 2026)</p>
                                <ul class="text-sm space-y-1 ml-4">
                                    <li>‚Ä¢ Free Kappa, M-spike, UPEP</li>
                                    <li>‚Ä¢ CBC, CMP</li>
                                    <li>‚Ä¢ Target: ‚â•50% FLC reduction</li>
                                </ul>
                            </div>
                            <div>
                                <p class="font-semibold mb-1">Week 12 Assessment (April 2026)</p>
                                <ul class="text-sm space-y-1 ml-4">
                                    <li>‚Ä¢ First MRD test</li>
                                    <li>‚Ä¢ Bone marrow biopsy if ‚â•CR</li>
                                    <li>‚Ä¢ Target: MRD-negative at 10‚Åª‚Åµ</li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
                
                <div class="bg-blue-50 border-l-4 border-blue-500 p-4">
                    <h4 class="font-bold mb-2">What This Means:</h4>
                    <p>Your excellent Day-5 response with preserved blood counts indicates that your myeloma cells are sensitive to Daratumumab and your bone marrow has strong reserve capacity. This bodes well for tolerating the planned Daratumumab monotherapy therapy and achieving deep responses including potential MRD-negativity.</p>
                </div>
            </div>
            

            <!-- Week 2 Labs Tab -->
            <div id="week2" class="tab-content p-6">
                <h3 class="text-2xl font-bold mb-4">Week 2 Post-Daratumumab Labs</h3>
                <p class="text-sm text-gray-600 mb-4">Collection: 01/02/2026 12:54 PM | Lab: Sonora Quest Laboratories</p>
                
                <div class="bg-green-50 border-l-4 border-green-500 p-6 mb-6">
                    <div class="flex items-center mb-4">
                        <i class="fas fa-check-circle text-4xl text-green-600 mr-4"></i>
                        <div>
                            <h4 class="font-bold text-2xl text-green-700">‚úÖ CONTINUED EXCELLENT RESPONSE</h4>
                            <p class="text-green-700">All blood counts remain within normal range - no myelosuppression at Week 2</p>
                        </div>
                    </div>
                </div>
                
                <div class="mb-6">
                    <h4 class="font-bold text-lg mb-3">CBC With Differential - Week 2</h4>
                    <div class="table-responsive">
                        <table>
                            <thead>
                                <tr>
                                    <th>Parameter</th>
                                    <th>Value</th>
                                    <th>Reference</th>
                                    <th>Status</th>
                                    <th>Trend</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr class="bg-green-50">
                                    <td>WBC</td>
                                    <td><strong>7.2 K/ŒºL</strong></td>
                                    <td>4.0-11.0</td>
                                    <td><span class="text-green-600 font-bold">‚úÖ Normal</span></td>
                                    <td><span class="text-gray-500">‚Üì from 9.4</span></td>
                                </tr>
                                <tr class="bg-green-50">
                                    <td>Hemoglobin</td>
                                    <td><strong>15.3 g/dL</strong></td>
                                    <td>13.5-17.0</td>
                                    <td><span class="text-green-600 font-bold">‚úÖ Normal</span></td>
                                    <td><span class="text-gray-500">‚Üì from 16.4</span></td>
                                </tr>
                                <tr class="bg-green-50">
                                    <td>Platelets</td>
                                    <td><strong>203 K/ŒºL</strong></td>
                                    <td>130-450</td>
                                    <td><span class="text-green-600 font-bold">‚úÖ Normal</span></td>
                                    <td><span class="text-gray-500">‚Üì from 293</span></td>
                                </tr>
                                <tr class="bg-green-50">
                                    <td>ANC (Neutrophils)</td>
                                    <td><strong>4.1 K/ŒºL</strong></td>
                                    <td>1.5-7.8</td>
                                    <td><span class="text-green-600 font-bold">‚úÖ Normal</span></td>
                                    <td><span class="text-gray-500">‚Üì from 5.3</span></td>
                                </tr>
                                <tr class="bg-green-50">
                                    <td>ALC (Lymphocytes)</td>
                                    <td><strong>2.3 K/ŒºL</strong></td>
                                    <td>0.9-3.9</td>
                                    <td><span class="text-green-600 font-bold">‚úÖ Normal</span></td>
                                    <td><span class="text-gray-500">‚Üì from 3.1</span></td>
                                </tr>
                                <tr>
                                    <td>RBC</td>
                                    <td>5.06 M/ŒºL</td>
                                    <td>4.30-6.00</td>
                                    <td><span class="text-green-600">‚úÖ Normal</span></td>
                                    <td>‚Äî</td>
                                </tr>
                                <tr>
                                    <td>Hematocrit</td>
                                    <td>45.5%</td>
                                    <td>40.0-53.0</td>
                                    <td><span class="text-green-600">‚úÖ Normal</span></td>
                                    <td><span class="text-gray-500">‚Üì from 46.4</span></td>
                                </tr>
                                <tr>
                                    <td>MCV</td>
                                    <td>89.9 fL</td>
                                    <td>78.0-100.0</td>
                                    <td><span class="text-green-600">‚úÖ Normal</span></td>
                                    <td>‚Äî</td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                </div>
                
                <div class="grid grid-cols-1 md:grid-cols-2 gap-6 mb-6">
                    <div class="luxury-card reveal p-6" style="background: linear-gradient(135deg, #10B981 0%, #059669 100%); color: white;">
                        <h4 class="font-bold text-xl mb-4">Clinical Interpretation</h4>
                        <ul class="space-y-3">
                            <li class="flex items-start">
                                <i class="fas fa-check-circle mr-2 mt-1"></i>
                                <span>All counts remain within normal limits</span>
                            </li>
                            <li class="flex items-start">
                                <i class="fas fa-check-circle mr-2 mt-1"></i>
                                <span>Mild decreases are expected and within range</span>
                            </li>
                            <li class="flex items-start">
                                <i class="fas fa-check-circle mr-2 mt-1"></i>
                                <span>No neutropenia, anemia, or thrombocytopenia</span>
                            </li>
                            <li class="flex items-start">
                                <i class="fas fa-check-circle mr-2 mt-1"></i>
                                <span>Immune function preserved (ALC 2.3)</span>
                            </li>
                        </ul>
                    </div>
                    
                    <div class="luxury-card reveal p-6" style="background: linear-gradient(135deg, #3B82F6 0%, #1E40AF 100%); color: white;">
                        <h4 class="font-bold text-xl mb-4">Next Steps</h4>
                        <div class="space-y-4">
                            <div>
                                <p class="font-semibold mb-1">Week 4 Labs (Due: January 18, 2026)</p>
                                <ul class="text-sm space-y-1 ml-4">
                                    <li>‚Ä¢ Free Kappa, M-spike, UPEP</li>
                                    <li>‚Ä¢ CBC, CMP</li>
                                    <li>‚Ä¢ Target: ‚â•50% FLC reduction</li>
                                </ul>
                            </div>
                            <div>
                                <p class="font-semibold mb-1">Continue Monitoring</p>
                                <ul class="text-sm space-y-1 ml-4">
                                    <li>‚Ä¢ Report any fever, bleeding, fatigue</li>
                                    <li>‚Ä¢ Stay hydrated</li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
                
                <div class="bg-blue-50 border-l-4 border-blue-500 p-4">
                    <h4 class="font-bold mb-2">Summary:</h4>
                    <p>Your Week 2 labs show continued excellent tolerance of Daratumumab. All counts remain solidly in normal range with no concerning drops. This is a very positive sign that your bone marrow is handling treatment well, which bodes well for adding the full Daratumumab monotherapy regimen.</p>
                </div>
            </div>

        </div>
    </section>

    <!-- Treatment Section -->
    <section id="treatment" class="mb-12">
        <h2 class="display-medium reveal">Treatment Plan</h2>
        
        <!-- Treatment Timeline -->
        <div class="luxury-card reveal p-8 mb-8">
            <h3 class="text-2xl font-bold mb-6">Treatment Roadmap</h3>

            <div class="mb-4 flex items-center text-sm text-gray-600">
                <i class="fas fa-info-circle mr-2" style="color: var(--secondary);"></i>
                <span>Your current position in the treatment journey is highlighted. Click phases for more details.</span>
            </div>


            <div class="mb-4 flex items-center text-sm text-gray-600">
                <i class="fas fa-info-circle mr-2" style="color: var(--secondary);"></i>
                <span>Your current position in the treatment journey is highlighted. Click phases for more details.</span>
            </div>

            <div class="relative">
                <div class="flex items-center justify-between mb-8 flex-wrap">
                    <div class="text-center flex-1 min-w-[150px] mb-4">
                        <div class="w-12 h-12 bg-green-500 rounded-full mx-auto mb-2 flex items-center justify-center text-white font-bold">‚úì</div>
                        <p class="font-semibold text-sm">12/21/25</p>
                        <p class="text-xs text-gray-600">Dara Start</p>
                    </div>
                    <div class="flex-1 h-1 bg-green-500 mb-4"></div>
                    <div class="text-center flex-1 min-w-[150px] mb-4">
                        <div class="w-12 h-12 rounded-full mx-auto mb-2 flex items-center justify-center text-white font-bold" style="background: var(--secondary);">NOW</div>
                        <p class="font-semibold text-sm">You Are Here</p>
                        <p class="text-xs text-gray-600">Day 5 Complete</p>
                    </div>
                    <div class="flex-1 h-1 bg-gray-300 mb-4"></div>
                    <div class="text-center flex-1 min-w-[150px] mb-4">
                        <div class="w-12 h-12 bg-gray-300 rounded-full mx-auto mb-2 flex items-center justify-center text-gray-600 font-bold">12</div>
                        <p class="font-semibold text-sm">Week 12</p>
                        <p class="text-xs text-gray-600">April 2026</p>
                    </div>
                </div>
                
                <div class="space-y-6">
                    <div class="border-l-4 pl-6" style="border-color: var(--secondary);">
                        <h4 class="font-bold text-lg mb-2">Phase 1: INDUCTION (Months 1-6)</h4>
                        <p class="text-gray-700 mb-2">Current: Daratumumab monotherapy</p>
                        <div class="bg-yellow-50 border border-yellow-200 rounded p-3">
                            <p class="text-yellow-800 font-semibold">‚ö†Ô∏è RECOMMENDATION: Escalate to Daratumumab monotherapy therapy given high-risk cytogenetics</p>
                        </div>
                    </div>
                    
                    <div class="border-l-4 border-gray-300 pl-6">
                        <h4 class="font-bold text-lg mb-2">Phase 2: CONSOLIDATION (Months 7-12) [PLANNED]</h4>
                        <p class="text-gray-700 mb-2">Daratumumab Monotherapy Therapy:</p>
                        <ul class="text-sm space-y-1 ml-4">
                            <li>‚Ä¢ Daratumumab 16 mg/kg IV weekly ‚Üí Q2W ‚Üí monthly</li>
                            
                            
                            
                        </ul>
                    </div>
                    
                    <div class="border-l-4 border-gray-300 pl-6">
                        <h4 class="font-bold text-lg mb-2">Phase 3: MAINTENANCE (Year 2+) [PLANNED]</h4>
                        <p class="text-gray-700">Dara-R (Daratumumab + Lenalidomide) until sustained MRD-negativity</p>
                    </div>
                </div>
            </div>
        </div>

        <!-- Daratumumab Drug Mechanisms -->
        <div class="luxury-card reveal p-8 mb-8">
            <h3 class="text-2xl font-bold mb-6">Daratumumab Monotherapy: How It Works</h3>
            <p class="text-gray-700 mb-6">Daratumumab attacking your myeloma from different angles:</p>
            
            <div class="space-y-4">
                <!-- Daratumumab Accordion -->
                <div>
                    <div class="accordion-header" onclick="toggleAccordion('dara-accordion')">
                        <div class="flex items-center justify-between">
                            <div class="flex items-center">
                                <i class="fas fa-syringe mr-3" style="color: var(--primary);"></i>
                                <span>üíâ DARATUMUMAB (Darzalex) - Anti-CD38 Monoclonal Antibody</span>
                            </div>
                            <i class="fas fa-chevron-down"></i>
                        </div>
                    </div>
                    <div id="dara-accordion" class="accordion-content">
                        <div class="p-6 bg-white rounded-lg">
                            
                            <h4 class="font-bold mb-3"><i class="fas fa-flask mr-2"></i>How It's Made - Interactive Animation:</h4>
                            <div style="background: #f8fafc; border-radius: 12px; padding: 20px; margin-bottom: 20px;">
                                <canvas id="cho-cell-animation" style="width: 100%; height: 320px;"></canvas>
                            </div>
                            
                            <h4 class="font-bold mb-3">Manufacturing Process:</h4>

                            <ul class="mb-4 space-y-1">
                                <li>‚Ä¢ Produced in CHO (Chinese Hamster Ovary) cells</li>
                                <li>‚Ä¢ Recombinant DNA technology</li>
                                <li>‚Ä¢ Purified via Protein A chromatography</li>
                                <li>‚Ä¢ Yields: ~10 g/L in optimized bioreactors</li>
                            </ul>
                            
                            <h4 class="font-bold mb-3">Mechanism of Action:</h4>
                            <div class="bg-blue-50 p-4 rounded mb-4">
                                <p class="text-center font-semibold mb-2">CD38 on Myeloma Cell ‚Üí Daratumumab Binds ‚Üí CDC + ADCC + ADCP ‚Üí Myeloma Cell Death</p>
                            </div>
                            
                            <h4 class="font-bold mb-2">How It Addresses YOUR 1q21 Gain:</h4>
                            <p class="mb-3">Direct killing independent of genetic abnormalities. Immune-mediated attack overwhelms Mcl-1 overexpression from amplified 1q21.</p>
                            
                            <h4 class="font-bold mb-2">How It Addresses YOUR TP53 Abnormality:</h4>
                            <p class="mb-3">Immune killing doesn't require p53 function. Bypasses apoptosis resistance from TP53 defects.</p>
                            
                            <div class="bg-green-50 border-l-4 border-green-500 p-3">
                                <p class="font-semibold mb-1">Clinical Data in High-Risk:</p>
                                <ul class="text-sm">
                                    <li>‚Ä¢ Part of Daratumumab: 54.8% MRD-negative (vs 32.4% RVd alone)</li>
                                    <li>‚Ä¢ Monotherapy PFS: 14 months (1q21 gain cohort)</li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
                
                
                </div>
                
                
                </div>
                
                
            </div>
            
            
            <!-- Interactive Drug Mechanism Animation -->
            <div class="luxury-card reveal p-6 mb-6">
                <h4 class="text-xl font-bold mb-4" style="color: var(--primary);"><i class="fas fa-crosshairs mr-2"></i>Watch How Daratumumab Attacks Your Cancer</h4>
                <p class="text-gray-600 mb-4">This animation shows how antibodies bind to CD38 receptors on your myeloma cells and trigger cell death.</p>
                <div style="background: #f8fafc; border-radius: 12px; padding: 20px;">
                    <canvas id="drug-mechanism-animation" style="width: 100%; height: 350px;"></canvas>
                </div>
            </div>

<!-- Synergy Diagram -->
            <div class="mt-8 card p-6" style="background: linear-gradient(135deg, #667EEA 0%, #764BA2 100%); color: white;">
                <h4 class="text-xl font-bold mb-4 text-center">How Daratumumab Attacks YOUR Myeloma</h4>
                <div class="text-center">
                    <div class="inline-block bg-white bg-opacity-20 rounded-lg p-6">
                        <p class="font-bold mb-3">YOUR MYELOMA CELL</p>
                        <p class="text-sm mb-3">(1q21 gain + TP53 abnormality + trisomies)</p>
                        <div class="text-center">
                            <div class="bg-white bg-opacity-30 p-4 rounded inline-block">
                                <p class="font-bold text-lg">DARATUMUMAB</p>
                                <p class="text-sm">Anti-CD38 Monoclonal Antibody</p>
                                <p class="text-sm mt-2">CDC + ADCC + ADCP ‚Üí Myeloma Cell Death</p>
                            </div>
                        </div>
                        <p class="font-bold mt-4 text-lg">‚Üì</p>
                        <p class="font-bold text-xl">CELL DEATH</p>
                    </div>
                </div>
                <p class="text-center mt-4 text-sm">Even with high-risk genetics, the immune-mediated attack overwhelms survival mechanisms and forces apoptosis.</p>
                <p class="text-center font-bold mt-2">TARGET: Achieve deep response with continued Daratumumab therapy</p>
            </div>
        </div>

        <!-- MRD Monitoring -->
        <div class="luxury-card reveal p-8 mb-8">
            <h3 class="text-2xl font-bold mb-6">MRD Monitoring Schedule</h3>
            
            <div class="bg-blue-50 border-l-4 border-blue-500 p-6 mb-6">
                <h4 class="font-bold text-lg mb-3">What Is MRD?</h4>
                <p class="mb-3">Minimal Residual Disease measures residual myeloma cells below complete response threshold.</p>
                <ul class="space-y-2">
                    <li><strong>Sensitivity:</strong> 1 cell in 100,000 (10‚Åª‚Åµ) or 1 in 1,000,000 (10‚Åª‚Å∂)</li>
                    <li><strong>Why it matters:</strong> MRD-negative patients live LONGER</li>
                    <li class="text-green-700 font-semibold">‚úì Median OS: 90 months vs 71 months (MRD+)</li>
                    <li class="text-green-700 font-semibold">‚úì Time to relapse: 87 months vs 44 months</li>
                    <li class="text-green-700 font-semibold">‚úì Can overcome high-risk cytogenetics ‚≠ê</li>
                </ul>
            </div>
            
            <h4 class="font-bold text-lg mb-4">YOUR Personalized MRD Timeline:</h4>
            <div class="space-y-4">
                <div class="luxury-card reveal p-4 border-l-4" style="border-color: var(--accent);">
                    <div class="flex items-start">
                        <i class="fas fa-calendar-check text-2xl mr-4" style="color: var(--accent);"></i>
                        <div class="flex-1">
                            <h5 class="font-bold">Week 12 (April 2026) - FIRST MRD TEST</h5>
                            <p class="text-sm text-gray-700 mb-2">Target: MRD-negative at 10‚Åª‚Åµ</p>
                            <p class="text-sm">If positive ‚Üí Continue Daratumumab 2 more cycles</p>
                        </div>
                    </div>
                </div>
                
                <div class="luxury-card reveal p-4 border-l-4 border-blue-500">
                    <div class="flex items-start">
                        <i class="fas fa-calendar-check text-2xl mr-4 text-blue-500"></i>
                        <div class="flex-1">
                            <h5 class="font-bold">Month 6 (July 2026) - SECOND MRD TEST</h5>
                            <p class="text-sm text-gray-700 mb-2">Target: MRD-negative at 10‚Åª‚Å∂ (deeper!)</p>
                            <p class="text-sm">If positive ‚Üí Consider CAR-T consolidation</p>
                        </div>
                    </div>
                </div>
                
                <div class="luxury-card reveal p-4 border-l-4 border-green-500">
                    <div class="flex items-start">
                        <i class="fas fa-calendar-check text-2xl mr-4 text-green-500"></i>
                        <div class="flex-1">
                            <h5 class="font-bold">Month 12 (January 2027) - SUSTAINED MRD CHECK</h5>
                            <p class="text-sm text-gray-700 mb-2">Target: Still MRD-negative (sustained!)</p>
                            <p class="text-sm">If sustained ‚Üí Continue maintenance, evaluate for treatment holiday</p>
                        </div>
                    </div>
                </div>
                
                <div class="luxury-card reveal p-4 border-l-4 border-purple-500">
                    <div class="flex items-start">
                        <i class="fas fa-calendar-alt text-2xl mr-4 text-purple-500"></i>
                        <div class="flex-1">
                            <h5 class="font-bold">Every 12 months thereafter</h5>
                            <p class="text-sm">Monitor for late relapse</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- CAR-T Quick Info -->
        <div class="luxury-card reveal p-8">
            <h3 class="text-2xl font-bold mb-6">CAR-T Cell Therapy (Backup Option)</h3>
            <div class="grid grid-cols-1 md:grid-cols-2 gap-6">
                <div>
                    <h4 class="font-bold mb-3">What It Is:</h4>
                    <p class="text-sm mb-4">YOUR OWN T-cells genetically modified to kill myeloma cells</p>
                    
                    <h4 class="font-bold mb-3">FDA-Approved Products:</h4>
                    <ul class="text-sm space-y-2 mb-4">
                        <li><strong>Idecabtagene vicleucel (ide-cel, Abecma)</strong></li>
                        <li><strong>Ciltacabtagene autoleucel (cilta-cel, Carvykti)</strong></li>
                    </ul>
                    
                    <h4 class="font-bold mb-3">Manufacturing Timeline:</h4>
                    <p class="text-sm">28-32 days from leukapheresis to infusion</p>
                    <p class="text-sm">Success rate: 93-96%</p>
                </div>
                
                <div>
                    <h4 class="font-bold mb-3">When Would You Need CAR-T?</h4>
                    <ul class="text-sm space-y-2 mb-4">
                        <li>‚Ä¢ If <PR at Week 12 with Daratumumab</li>
                        <li>‚Ä¢ If MRD-positive at Month 6</li>
                        <li>‚Ä¢ If early relapse (<18 months)</li>
                    </ul>
                    
                    <h4 class="font-bold mb-3">Expected Outcomes (High-Risk):</h4>
                    <ul class="text-sm space-y-1">
                        <li>‚Ä¢ ORR: 73-98%</li>
                        <li>‚Ä¢ Median PFS: 12-24 months</li>
                        <li>‚Ä¢ 5-year PFS: 33% (cilta-cel)</li>
                    </ul>
                </div>
            </div>
            
            <div class="mt-6 bg-purple-50 border-l-4 border-purple-500 p-4">
                <p class="font-semibold mb-2">How CAR-T Overcomes YOUR High-Risk Genetics:</p>
                <ul class="text-sm space-y-1">
                    <li>‚Ä¢ <strong>1q21 gain:</strong> Perforin/granzyme killing overwhelms Mcl-1 overexpression</li>
                    <li>‚Ä¢ <strong>TP53 abnormality:</strong> Extrinsic apoptosis bypasses p53 pathway</li>
                </ul>
            </div>
        </div>
    </section>

    <!-- Prognosis Section -->
    <section id="prognosis" class="mb-12">
        <h2 class="display-medium reveal">Prognosis & Life Expectancy</h2>
        
        <!-- Survival Calculator -->
        <div class="luxury-card reveal p-8 mb-8">
            <h3 class="text-2xl font-bold mb-6">YOUR Personalized Survival Calculator</h3>
            
            <div class="mb-8">
                <h4 class="font-bold text-lg mb-4">Input Parameters:</h4>
                <div class="grid grid-cols-1 md:grid-cols-3 gap-4 mb-6">
                    <div>
                        <label class="block text-sm font-semibold mb-2">Age at Diagnosis:</label>
                        <input type="number" value="57" class="w-full p-2 border rounded" disabled>
                    </div>
                    <div>
                        <label class="block text-sm font-semibold mb-2">Cytogenetics:</label>
                        <select class="w-full p-2 border rounded">
                            <option selected>High-Risk (1q21+TP53)</option>
                        </select>
                    </div>
                    <div>
                        <label class="block text-sm font-semibold mb-2">Treatment Response:</label>
                        <select id="response-selector" class="w-full p-2 border rounded" onchange="updatePrognosisScenario()">
                            <option value="mrd-neg">MRD-negative at 10‚Åª‚Åµ</option>
                            <option value="mrd-pos">MRD-positive, ‚â•PR</option>
                            <option value="refractory"><PR, refractory</option>
                        </select>
                    </div>
                </div>
            </div>
            
            <!-- Survival Scenarios -->
            <div class="space-y-6">
                <div class="survival-scenario" style="border-color: var(--secondary);">
                    <div class="flex items-center justify-between mb-3">
                        <h4 class="font-bold text-lg">Scenario A: MRD-NEGATIVE</h4>
                        <span class="px-3 py-1 bg-green-100 text-green-800 rounded-full text-sm font-semibold">50% probability</span>
                    </div>
                    <div class="mb-3">
                        <p class="font-semibold mb-2">Median Survival: 15-25+ years</p>
                        <div class="flex items-center space-x-4 text-sm mb-2">
                            <span>5-year: <strong>90%</strong></span>
                            <span>10-year: <strong>45%</strong></span>
                            <span>20-year: <strong>20%</strong></span>
                        </div>
                        <div class="progress-bar">
                            <div class="progress-fill" style="width: 80%;"></div>
                        </div>
                        <p class="text-sm text-gray-600 mt-2">Most likely outcome: Live to age 72-82 (year 2040-2050)</p>
                    </div>
                </div>
                
                <div class="survival-scenario">
                    <div class="flex items-center justify-between mb-3">
                        <h4 class="font-bold text-lg">Scenario B: MRD-POSITIVE</h4>
                        <span class="px-3 py-1 bg-yellow-100 text-yellow-800 rounded-full text-sm font-semibold">35% probability</span>
                    </div>
                    <div class="mb-3">
                        <p class="font-semibold mb-2">Median Survival: 8-15 years</p>
                        <div class="flex items-center space-x-4 text-sm mb-2">
                            <span>5-year: <strong>65%</strong></span>
                            <span>10-year: <strong>35%</strong></span>
                            <span>20-year: <strong>10%</strong></span>
                        </div>
                        <div class="progress-bar">
                            <div class="progress-fill" style="width: 60%; background: #F59E0B;"></div>
                        </div>
                        <p class="text-sm text-gray-600 mt-2">Multiple relapses requiring salvage: Live to age 65-72 (year 2033-2040)</p>
                    </div>
                </div>
                
                <div class="survival-scenario">
                    <div class="flex items-center justify-between mb-3">
                        <h4 class="font-bold text-lg">Scenario C: REFRACTORY</h4>
                        <span class="px-3 py-1 bg-red-100 text-red-800 rounded-full text-sm font-semibold">15% probability</span>
                    </div>
                    <div class="mb-3">
                        <p class="font-semibold mb-2">Median Survival: 5-8 years</p>
                        <div class="flex items-center space-x-4 text-sm mb-2">
                            <span>5-year: <strong>45%</strong></span>
                            <span>10-year: <strong>20%</strong></span>
                            <span>20-year: <strong>5%</strong></span>
                        </div>
                        <div class="progress-bar">
                            <div class="progress-fill" style="width: 40%; background: #EF4444;"></div>
                        </div>
                        <p class="text-sm text-gray-600 mt-2">Aggressive disease: Live to age 62-65 (year 2030-2033)</p>
                    </div>
                </div>
            </div>
            
            <div class="mt-8 p-6" style="background: linear-gradient(135deg, #667EEA 0%, #764BA2 100%); color: white; border-radius: 12px;">
                <h4 class="font-bold text-xl mb-3">INTEGRATED ESTIMATE FOR YOU:</h4>
                <p class="text-lg mb-2"><strong>Most likely survival:</strong> 12-18 years (to age 69-75)</p>
                <p class="mb-2"><strong>Quality of life average:</strong> 70-80%</p>
                <p class="text-sm">With MRD-negative response to Daratumumab, you have a 20-25% chance of beating these odds and living 20-25+ years to age 77-82.</p>
            </div>
        </div>

        <!-- Quality of Life Timeline Chart -->
        <div class="luxury-card reveal p-8 mb-8">
            <h3 class="text-2xl font-bold mb-6">Expected Quality of Life Trajectory</h3>
            <div class="chart-container">
                <canvas id="qolChart"></canvas>
            </div>
            <div class="mt-4 grid grid-cols-1 md:grid-cols-4 gap-4 text-sm">
                <div class="p-3 bg-blue-50 rounded">
                    <p class="font-semibold">Phase 1 (0-3 yrs)</p>
                    <p class="text-xs">Treatment-heavy, side effects</p>
                </div>
                <div class="p-3 bg-green-50 rounded">
                    <p class="font-semibold">Phase 2 (3-7 yrs)</p>
                    <p class="text-xs">Maintenance, improving function</p>
                </div>
                <div class="p-3 bg-yellow-50 rounded">
                    <p class="font-semibold">Phase 3 (7-15 yrs)</p>
                    <p class="text-xs">Remission or salvage, variable QOL</p>
                </div>
                <div class="p-3 bg-purple-50 rounded">
                    <p class="font-semibold">Phase 4 (15+ yrs)</p>
                    <p class="text-xs">Functional cure or palliative</p>
                </div>
            </div>
        </div>

        <!-- What Will Degrade -->
        <div class="luxury-card reveal p-8">
            <h3 class="text-2xl font-bold mb-6">What Will Degrade Over Time</h3>
            <div class="grid grid-cols-1 md:grid-cols-2 gap-6">
                <div>
                    <h4 class="font-bold text-lg mb-3 flex items-center">
                        <i class="fas fa-body mr-2" style="color: var(--accent);"></i>
                        Physical Function
                    </h4>
                    <ul class="space-y-2 text-sm">
                        <li class="flex items-start">
                            <i class="fas fa-check-square mr-2 mt-1" style="color: var(--accent);"></i>
                            <span><strong>Peripheral neuropathy</strong> (60% risk, persistent)</span>
                        </li>
                        <li class="flex items-start">
                            <i class="fas fa-check-square mr-2 mt-1" style="color: var(--accent);"></i>
                            <span><strong>Chronic fatigue</strong> (improves but never fully resolves)</span>
                        </li>
                        <li class="flex items-start">
                            <i class="fas fa-check-square mr-2 mt-1" style="color: var(--accent);"></i>
                            <span><strong>Bone density loss</strong> (osteoporosis, fracture risk)</span>
                        </li>
                        <li class="flex items-start">
                            <i class="fas fa-check-square mr-2 mt-1" style="color: var(--accent);"></i>
                            <span><strong>Immune compromise</strong> (ongoing infection risk)</span>
                        </li>
                        <li class="flex items-start">
                            <i class="fas fa-check-square mr-2 mt-1" style="color: var(--accent);"></i>
                            <span><strong>Metabolic changes</strong> (weight gain, diabetes risk)</span>
                        </li>
                    </ul>
                </div>
                
                <div>
                    <h4 class="font-bold text-lg mb-3 flex items-center">
                        <i class="fas fa-brain mr-2" style="color: var(--accent);"></i>
                        Cognitive & Emotional
                    </h4>
                    <ul class="space-y-2 text-sm">
                        <li class="flex items-start">
                            <i class="fas fa-check-square mr-2 mt-1" style="color: var(--accent);"></i>
                            <span><strong>"Chemo brain"</strong> (memory, concentration issues)</span>
                        </li>
                        <li class="flex items-start">
                            <i class="fas fa-check-square mr-2 mt-1" style="color: var(--accent);"></i>
                            <span><strong>Anxiety/depression</strong> (40-60% of patients)</span>
                        </li>
                        <li class="flex items-start">
                            <i class="fas fa-check-square mr-2 mt-1" style="color: var(--accent);"></i>
                            <span><strong>PTSD</strong> from treatment experience</span>
                        </li>
                    </ul>
                    
                    <h4 class="font-bold text-lg mb-3 mt-6 flex items-center">
                        <i class="fas fa-users mr-2" style="color: var(--accent);"></i>
                        Social & Occupational
                    </h4>
                    <ul class="space-y-2 text-sm">
                        <li class="flex items-start">
                            <i class="fas fa-check-square mr-2 mt-1" style="color: var(--accent);"></i>
                            <span><strong>Work capacity reduced</strong> (may need disability)</span>
                        </li>
                        <li class="flex items-start">
                            <i class="fas fa-check-square mr-2 mt-1" style="color: var(--accent);"></i>
                            <span><strong>Financial strain</strong> (medical debt, lost income)</span>
                        </li>
                        <li class="flex items-start">
                            <i class="fas fa-check-square mr-2 mt-1" style="color: var(--accent);"></i>
                            <span><strong>Social isolation</strong> (infection risk limits activities)</span>
                        </li>
                    </ul>
                </div>
            </div>
            
            <div class="mt-6 bg-yellow-50 border-l-4 border-yellow-500 p-4">
                <h4 class="font-bold mb-2">The Reality:</h4>
                <p class="text-sm">Your first 5 years will be hard (treatment, side effects). Years 6-12 will be better (maintenance or off therapy). Years 13+ depend on whether you relapse. But you'll still be able to work (part-time), travel (with planning), enjoy relationships, and live a meaningful life.</p>
            </div>
        </div>
    </section>

    <!-- Resources Section -->
    <section id="resources" class="mb-12">
        <h2 class="display-medium reveal">Patient Resources & Tools</h2>
        
        <div class="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-3 gap-6">
            <!-- Appointment Tools -->
            <div class="luxury-card reveal p-6">
                <i class="fas fa-clipboard-list text-4xl mb-4" style="color: var(--primary);"></i>
                <h3 class="font-bold text-lg mb-3">Appointment Tools</h3>
                <ul class="space-y-2 text-sm">
                    <li><a href="lab-tracker.html" target="_blank" class="text-blue-600 hover:underline">üìÑ Pocket Lab Summary (1-page)</a></li>
                    <li><a href="eric_miller_intensified_therapy_complete_guide.pdf" target="_blank" class="text-blue-600 hover:underline">üìÑ Full Discussion Outline / Intensified Therapy Guide</a></li>
                    <li><a href="lab-tracker.html" target="_blank" class="text-blue-600 hover:underline">üìÑ Lab Tracker (Printable)</a></li>
                    <li><a href="question-checklist.html" target="_blank" class="text-blue-600 hover:underline">üìÑ Question Checklist</a></li>
                </ul>
            </div>
            
            <!-- Diagnostic Reports -->
            <div class="luxury-card reveal p-6">
                <i class="fas fa-file-medical text-4xl mb-4" style="color: var(--primary);"></i>
                <h3 class="font-bold text-lg mb-3">Diagnostic Reports</h3>
                <ul class="space-y-2 text-sm">
                    <li><a href="eric_miller_fish_visualization.pdf" target="_blank" class="text-blue-600 hover:underline">üìÑ FISH Visual Report</a></li>
                    <li><a href="#diagnostics" onclick="setTimeout(()=>switchTab('bone-marrow'),100)" class="text-blue-600 hover:underline">üìÑ Bone Marrow Pathology</a></li>
                    <li><a href="#diagnostics" onclick="setTimeout(()=>switchTab('baseline-labs'),100)" class="text-blue-600 hover:underline">üìÑ Baseline Labs</a></li>
                    <li><a href="IgG Kappa Monoclonal Gammopathy Diagnostic Analysis.pdf" target="_blank" class="text-blue-600 hover:underline">üìÑ Complete Diagnostic Analysis</a></li>
                </ul>
            </div>
            
            <!-- Treatment Guides -->
            <div class="luxury-card reveal p-6">
                <i class="fas fa-book-medical text-4xl mb-4" style="color: var(--primary);"></i>
                <h3 class="font-bold text-lg mb-3">Treatment Guides</h3>
                <ul class="space-y-2 text-sm">
                    <li><a href="#treatment" class="text-blue-600 hover:underline" onclick="setTimeout(()=>document.querySelector('#treatment').scrollIntoView({behavior:'smooth'}),100)">üìÑ Daratumumab Complete Protocol</a></li>
                    <li><a href="#treatment" class="text-blue-600 hover:underline" onclick="setTimeout(()=>document.querySelector('#treatment').scrollIntoView({behavior:'smooth'}),100)">üìÑ MRD Monitoring Guide</a></li>
                    <li><a href="#treatment" class="text-blue-600 hover:underline" onclick="setTimeout(()=>document.querySelector('#treatment').scrollIntoView({behavior:'smooth'}),100)">üìÑ CAR-T Patient Info</a></li>
                    <li><a href="eric_miller_intensified_therapy_complete_guide.pdf" target="_blank" class="text-blue-600 hover:underline">üìÑ Side Effect Guide (PDF)</a></li>
                </ul>
            </div>
            
            <!-- External Resources -->
            <div class="luxury-card reveal p-6">
                <i class="fas fa-external-link-alt text-4xl mb-4" style="color: var(--primary);"></i>
                <h3 class="font-bold text-lg mb-3">External Resources</h3>
                <ul class="space-y-2 text-sm">
                    <li><a href="https://clinicaltrials.gov" target="_blank" class="text-blue-600 hover:underline">üîó ClinicalTrials.gov</a></li>
                    <li><a href="https://myelomacrowd.org" target="_blank" class="text-blue-600 hover:underline">üîó Myeloma Crowd</a></li>
                    <li><a href="https://www.myeloma.org" target="_blank" class="text-blue-600 hover:underline">üîó IMF (Int'l Myeloma Foundation)</a></li>
                    <li><a href="https://www.patientadvocate.org" target="_blank" class="text-blue-600 hover:underline">üîó Patient Advocate Foundation</a></li>
                </ul>
            </div>
            
            <!-- Quick Actions -->
            <div class="luxury-card reveal p-6" style="background: linear-gradient(135deg, var(--primary) 0%, var(--secondary) 100%); color: white;">
                <i class="fas fa-bolt text-4xl mb-4"></i>
                <h3 class="font-bold text-lg mb-3">Quick Actions</h3>
                <div class="space-y-2">
                    <button onclick="window.print()" class="w-full bg-white text-gray-900 py-2 rounded font-semibold hover:bg-gray-100">
                        <i class="fas fa-print mr-2"></i>Print This Page
                    </button>
                    <button onclick="alert('Download functionality coming soon')" class="w-full bg-white text-gray-900 py-2 rounded font-semibold hover:bg-gray-100">
                        <i class="fas fa-download mr-2"></i>Download All PDFs
                    </button>
                    <button onclick="alert('Email: eric.miller@example.com')" class="w-full bg-white text-gray-900 py-2 rounded font-semibold hover:bg-gray-100">
                        <i class="fas fa-envelope mr-2"></i>Email to Doctor
                    </button>
                </div>
            </div>
        </div>
    </section>

</main>

<!-- Footer -->
<footer class="bg-gray-800 text-white py-8 mt-12 no-print">
    <div class="container mx-auto px-4">
        <div class="grid grid-cols-1 md:grid-cols-3 gap-8">
            <div>
                <h4 class="font-bold text-lg mb-3">Contact Information</h4>
                <p class="text-sm mb-2"><i class="fas fa-hospital mr-2"></i>Ironwood Cancer Center</p>
                <p class="text-sm mb-2"><i class="fas fa-phone mr-2"></i>(480) 323-1339</p>
                <p class="text-sm mb-2"><i class="fas fa-user-md mr-2"></i>Dr. Rakesh Bagai, MD</p>
                <p class="text-sm"><i class="fas fa-exclamation-triangle mr-2"></i>24/7 Emergency: Call Above</p>
            </div>
            <div>
                <h4 class="font-bold text-lg mb-3">Important Dates</h4>
                <p class="text-sm mb-2">Diagnosis: November 7, 2025</p>
                <p class="text-sm mb-2">Treatment Start: December 21, 2025</p>
                <p class="text-sm mb-2">Week 4 Labs: January 18, 2026</p>
                <p class="text-sm">Week 12 Assessment: April 2026</p>
            </div>
            <div>
                <h4 class="font-bold text-lg mb-3">Disclaimer</h4>
                <p class="text-xs">This site is for personal medical record organization only. Always consult your physician for medical decisions. Information presented here is based on current medical literature and your specific test results as of January 1, 2026.</p>
            </div>
        </div>
        <div class="border-t border-gray-700 mt-6 pt-6 text-center">
            <p class="text-sm">¬© 2026 Eric J. Miller Medical Portal | Private & Secure</p>
            <p class="text-xs mt-2">Last Updated: 14 Jan 2026 | Next Review: Week 4 Labs</p>
        </div>
    </div>
</footer>

<script>
// Dark Mode Toggle
function toggleDarkMode() {
    document.body.classList.toggle('dark-mode');
    localStorage.setItem('darkMode', document.body.classList.contains('dark-mode'));
}

// Font Size Adjustment
let fontSize = 16;
function adjustFontSize(action) {
    if (action === 'increase' && fontSize < 20) {
        fontSize += 2;
    } else if (action === 'decrease' && fontSize > 12) {
        fontSize -= 2;
    }
    document.body.style.fontSize = fontSize + 'px';
    localStorage.setItem('fontSize', fontSize);
}

// Scroll to Section
function scrollToSection(id) {
    document.getElementById(id).scrollIntoView({ behavior: 'smooth' });
}

// Tab Switching
function switchTab(tabId) {
    // Hide all tab contents
    document.querySelectorAll('.tab-content').forEach(content => {
        content.classList.remove('active');
    });
    
    // Remove active class from all tab buttons
    document.querySelectorAll('.tab-button').forEach(button => {
        button.classList.remove('active');
    });
    
    // Show selected tab content
    document.getElementById(tabId).classList.add('active');
    
    // Add active class to clicked button (if called from tab button)
    event.target.classList.add('active');
}

// Accordion Toggle
function toggleAccordion(id) {
    const content = document.getElementById(id);
    content.classList.toggle('open');
    
    // Rotate chevron
    const header = content.previousElementSibling;
    const chevron = header.querySelector('.fa-chevron-down');
    if (content.classList.contains('open')) {
        chevron.style.transform = 'rotate(180deg)';
    } else {
        chevron.style.transform = 'rotate(0deg)';
    }
}

// Update Prognosis Scenario
function updatePrognosisScenario() {
    const selector = document.getElementById('response-selector');
    const value = selector.value;
    
    // Highlight the selected scenario
    document.querySelectorAll('.survival-scenario').forEach(scenario => {
        scenario.style.borderWidth = '2px';
    });
    
    if (value === 'mrd-neg') {
        document.querySelectorAll('.survival-scenario')[0].style.borderWidth = '4px';
    } else if (value === 'mrd-pos') {
        document.querySelectorAll('.survival-scenario')[1].style.borderWidth = '4px';
    } else {
        document.querySelectorAll('.survival-scenario')[2].style.borderWidth = '4px';
    }
}

// Quality of Life Chart
window.addEventListener('load', function() {
    const ctx = document.getElementById('qolChart').getContext('2d');
    new Chart(ctx, {
        type: 'line',
        data: {
            labels: ['0', '1', '2', '3', '4', '5', '6', '7', '8', '9', '10', '11', '12', '13', '14', '15', '16', '17', '18', '19', '20'],
            datasets: [{
                label: 'Best Case (MRD-negative)',
                data: [95, 70, 75, 80, 85, 85, 87, 88, 90, 90, 90, 90, 90, 90, 90, 90, 88, 87, 85, 83, 80],
                borderColor: '#10B981',
                backgroundColor: 'rgba(16, 185, 129, 0.1)',
                tension: 0.4,
                borderWidth: 3
            }, {
                label: 'Most Likely (Partial Response)',
                data: [95, 65, 70, 72, 75, 75, 77, 78, 75, 73, 70, 68, 65, 63, 60, 58, 55, 53, 50, null, null],
                borderColor: '#F59E0B',
                backgroundColor: 'rgba(245, 158, 11, 0.1)',
                tension: 0.4,
                borderWidth: 3
            }, {
                label: 'Worst Case (Refractory)',
                data: [95, 55, 60, 58, 55, 53, 50, 48, 45, 43, 40, 38, 35, null, null, null, null, null, null, null, null],
                borderColor: '#EF4444',
                backgroundColor: 'rgba(239, 68, 68, 0.1)',
                tension: 0.4,
                borderWidth: 3
            }]
        },
        options: {
            responsive: true,
            maintainAspectRatio: false,
            plugins: {
                title: {
                    display: true,
                    text: 'Quality of Life Over Time (% of Baseline)',
                    font: { size: 16, weight: 'bold' }
                },
                legend: {
                    display: true,
                    position: 'bottom'
                }
            },
            scales: {
                y: {
                    beginAtZero: true,
                    max: 100,
                    title: {
                        display: true,
                        text: 'Quality of Life (%)'
                    }
                },
                x: {
                    title: {
                        display: true,
                        text: 'Years Since Diagnosis'
                    }
                }
            }
        }
    });
    
    // Load saved preferences
    if (localStorage.getItem('darkMode') === 'true') {
        document.body.classList.add('dark-mode');
    }
    
    const savedFontSize = localStorage.getItem('fontSize');
    if (savedFontSize) {
        fontSize = parseInt(savedFontSize);
        document.body.style.fontSize = fontSize + 'px';
    }
});

// Smooth scroll for all internal links
document.querySelectorAll('a[href^="#"]').forEach(anchor => {
    anchor.addEventListener('click', function (e) {
        e.preventDefault();
        const target = document.querySelector(this.getAttribute('href'));
        if (target) {
            target.scrollIntoView({ behavior: 'smooth' });
        }
    });
});
</script>


<script src="js/animations.js"></script>
    <script src="js/lab-entry.js"></script>

<script>
    // Luxury reveal animations
    const observerOptions = {
        threshold: 0.1,
        rootMargin: '0px 0px -50px 0px'
    };
    
    const revealObserver = new IntersectionObserver((entries) => {
        entries.forEach(entry => {
            if (entry.isIntersecting) {
                entry.target.classList.add('visible');
            }
        });
    }, observerOptions);
    
    document.addEventListener('DOMContentLoaded', () => {
        document.querySelectorAll('.reveal, .stagger-fade').forEach(el => {
            revealObserver.observe(el);
        });
        
        // Nav scroll effect
        const nav = document.querySelector('.luxury-nav');
        if (nav) {
            window.addEventListener('scroll', () => {
                if (window.scrollY > 50) {
                    nav.classList.add('scrolled');
                } else {
                    nav.classList.remove('scrolled');
                }
            });
        }
    });
</script>
</body>
</html>
    
    
    
    